[HTML][HTML] Adherence to omalizumab: A multicenter" real-world" study
R Campisi, C Crimi, R Intravaia… - World Allergy …, 2020 - worldallergyorganizationjournal.org
Background Adherence to medications is crucial in patients with severe asthma in light of
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
Adherence to omalizumab: A multicenter “real-world” study
R Campisi, C Crimi, R Intravaia, S Strano… - THE WORLD …, 2020 - fair.unifg.it
Background: Adherence to medications is crucial in patients with severe asthma in light of
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
[PDF][PDF] Adherence to omalizumab: A multicenter" real-world" study
R Campisia, C Crimia, R Intravaiab, S Stranob, A Notoc… - World - academia.edu
Background: Adherence to medications is crucial in patients with severe asthma in light of
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
Adherence to omalizumab: A multicenter" real-world" study
R Campisi, C Crimi, R Intravaia… - The World Allergy …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Adherence to medications is crucial in patients with severe asthma in light of
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
[PDF][PDF] Adherence to omalizumab: A multicenter" real-world" study
R Campisi, C Crimi, R Intravaia, S Strano, A Noto… - World - iris.unipa.it
Background: Adherence to medications is crucial in patients with severe asthma in light of
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
[引用][C] Adherence to omalizumab: A multicenter" real-world" study
R Campisi, C Crimi, R Intravaia, S Strano… - World Allergy …, 2020 - cir.nii.ac.jp
Adherence to omalizumab: A multicenter "real-world" study | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[HTML][HTML] Adherence to omalizumab: A multicenter" real-world" study
R Campisi, C Crimi, R Intravaia, S Strano… - The World Allergy …, 2020 - ncbi.nlm.nih.gov
Background Adherence to medications is crucial in patients with severe asthma in light of
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
[引用][C] Adherence to omalizumab: A multicenter" real-world" study
R Campisi, C Crimi, R Intravaia, S Strano… - THE WORLD …, 2020 - iris.unime.it
[PDF][PDF] Adherence to omalizumab: A multicenter" real-world" study
R Campisi, C Crimi, R Intravaia, S Strano, A Noto… - World - iris.unict.it
Background: Adherence to medications is crucial in patients with severe asthma in light of
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
[PDF][PDF] Adherence to omalizumab: A multicenter" real-world" study
R Campisi, C Crimi, R Intravaia, S Strano, A Noto… - World - researchgate.net
Background: Adherence to medications is crucial in patients with severe asthma in light of
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …
the negative clinical impact and costs of non-adherence. Adherence to omalizumab has not …